skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: In trying to decide which ETF’s to buy, I am concerned with the credit duration of some.
Ex: XTR 3.78 yrs. ZMI 3.77 yrs. VCNS 7.82 yrs
What is the significance of these in view of the current business cycle mainly interest rates.
Also, at this time would you favour an ETF more or less exposed to bonds currently. Is a fund manager able to quickly sell his bond holdings quickly when interest rates rise, what is their strategy ?
Thank you so much.
Read Answer Asked by Luc on January 08, 2020
Q: Class F Capital Shares (the "Federation Capital Shares") . These are offered by caisse desjardins. We have some older "permanent" shares which Desjardins wants us to exchange for capital shares. I didnt buy these and i am not even sure what they are. They almost seem to be a kind of preferred share. Just wondering with your wide expertise whether you know exactly what these are. And more importantly, whether they are worth holding. I am thinking no.
Thankyou for any help and all the best in the new year
Read Answer Asked by joseph on January 08, 2020
Q: Hi, Enghouse shares shot up 3% on Tuesday, with large volume. Do you think that shares are being rerated after staying quiet for a long period? I have read your views on the company and it appears that it's one of your longtime favorites (also included in your list of Top 10 companies to own for next 10 years). Is it reasonable to start a new position 1-2%, at current levels ? We also own CSU as a large holding (10%). How does ENGH valuation compare with CSU ? Thank You
Read Answer Asked by rajeev on January 08, 2020
Q: LYB shares APPEAR to be good value. Analyst opinions however are all over the spectrum. For example RBC Cap downgraded LYB to hold/neutral from outperform; CFRA has a STRONG buy. I have reviewed Forward P/E , PEG and other quant metrics. What do you think of qualitative aspects? What is your substantive insight into LYB’s BUSINESS model? Based on what you read and your own thoughts on prospects for global growth, is LYB a good holding? It has been a dividend grower but share price is flat to lower for a while. Do you think chances for growth in EPS, and price of shares going forward, is one better to move on? I checked your previous response to on LYB and am looking for more your current thinking.
Read Answer Asked by Adam on January 08, 2020
Q: I am not clear on your December 23 comment on Gilead. You write that GILD has (or may have been) a “value trap” . You do not say whether your view is to sell. Is it your thinking that GILD is a hold? Or did you mean to say it is likely better to sell GILD? I am not sure how 5i defines value trap and you did not elaborate. One acknowledges that your comments are not advice.... that’s understood. With that in mind, I would appreciate more clarity on your thinking. Several pharma and bio tech companies are frustrating securities to hold. But sometimes the pipeline or prospects make the risk-reward equation such that patience is advised. Is it here?
Read Answer Asked by Adam on January 08, 2020
Q: Hi there,

I have a fairly heavy weighting of SIS that is about break even. I'm tiring of waiting for it and wonder what your advice would be on selling SIS to establish 3 equal weighted positions in VRTX, EXAS and ISRG? My thinking is I like the medical exposure and they are nicely diversified. Do you like this move and would you choose these 3 companies or suggest an alternative?

Thanks
Read Answer Asked by Tim on January 07, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!